Yahoo
NasdaqGM - Delayed Quote USD

Drugs Made In America Acquisition Corp. (DMAAU)

11.01 0.00 (0.00%)
At close: November 3 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
Total Revenue
0 0
Selling, General and Administrative Expenses
-2,633.40 -2,816.01
Operating Income/Expenses
-2,633.40 -2,816.01
Total Operating Profit/Loss
-2,633.40 -2,816.01
Total Net Finance Income/Expense
8,728.28 8,756.66
Non-Operating Income/Expenses, Total
8,728.28 8,756.66
Pretax Income
6,094.88 5,940.64
Net Income from Continuing Operations
6,094.88 5,940.64
Net Income after Extraordinary Items and Discontinued Operations
6,094.88 5,940.64
Net Income after Non-Controlling/Minority Interests
6,094.88 5,940.64
Net Income Available to Common Stockholders
6,094.88 5,940.64
Diluted Net Income Available to Common Stockholders
6,094.88 5,940.64
Income Statement, Supplemental
EBIT
-2,633.40 -2,816.01
EBITDA
-2,633.40 -2,816.01
Normalized EBITDA
-2,633.40 -2,816.01
Normalized Income
6,094.88 5,940.64
Total Unusual Items
0 0
Total Unusual Items Excluding Goodwill
0 0
Tax Effect of Unusual Items
0 0
Tax Rate, Calculated
0.00 0.00
12/31/2025 - 1/28/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: